Tilray Brands Inc. announced that its pharmaceutical division, Tilray Pharma, through its European distribution business CC Pharma, has entered into a strategic agreement with Smartway Pharmaceuticals, a UK-based pharmaceutical distribution partner. The agreement aims to expand the availability of pharmaceutical products across the United Kingdom by leveraging Smartway's distribution infrastructure and CC Pharma's European procurement and GMP capacity. Both parties will support the expansion of parallel import and specialist pharmaceutical supply in the UK and will explore additional opportunities for collaboration.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tilray Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9653381-en) on February 12, 2026, and is solely responsible for the information contained therein.